Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline, not by an editor. They are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
8082 items from SEC EDGAR · clear filters
- 8-K - Armata Pharmaceuticals, Inc. (0000921114) (Filer)
Automated noteArmata Pharmaceuticals, Inc. filed a Form 8-K on September 14, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).
- 8-K - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Filer)
Automated noteCorbus Pharmaceuticals filed a Form 8-K on September 14, 2026, containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - Bally's Corp (0001747079) (Filer)
Automated noteBally's Corp filed a Form 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, other events, and accompanying financial statements and exhibits.
- 8-K - FLOWSERVE CORP (0000030625) (Filer)
Automated noteFlowserve Corp filed a Form 8-K on September 14, 2026, reporting director and officer departures, elections, appointments and related compensation arrangements, providing a Regulation FD disclosure, and attaching financial statements and related exhibits.
- 8-K - HAIN CELESTIAL GROUP INC (0000910406) (Filer)
Automated noteHain Celestial Group Inc. filed a Form 8-K on September 14, 2026 reporting a material definitive agreement, its recent operating results and financial condition, changes to directors and officers, and accompanying financial statements and exhibits.
- 8-K - Brookfield Asset Management Ltd. (0001937926) (Filer)
Automated noteBrookfield Asset Management Ltd. filed a Form 8-K on September 14, 2026 (Accession No. 0001171843-26-006022, 215 KB), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.
- 8-K - TOYOTA MOTOR CREDIT CORP (0000834071) (Filer)
Automated noteToyota Motor Credit Corp filed a Form 8-K on September 14, 2026, reporting a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, and accompanying financial statements and exhibits.
- 8-K - American Healthcare REIT, Inc. (0001632970) (Filer)
Automated noteAmerican Healthcare REIT, Inc. filed a Form 8-K on September 14, 2026, providing a Regulation FD disclosure under Item 7.01.
- 8-K - STATE STREET CORP (0000093751) (Filer)
Automated noteState Street Corp filed a Form 8-K on September 14, 2026, disclosing departures, elections or appointments of directors and certain officers along with related compensatory arrangements, and providing its financial statements and accompanying exhibits.
- 8-K - ADDENTAX GROUP CORP. (0001650101) (Filer)
Automated noteAddentax Group Corp. filed a Form 8-K reporting entry into a material definitive agreement, unregistered sales of equity securities, and the inclusion of its financial statements and related exhibits.
- 8-K - Perspective Therapeutics, Inc. (0000728387) (Filer)
Automated notePerspective Therapeutics, Inc. filed a Form 8-K with the SEC on September 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Lipocine Inc. (0001535955) (Filer)
Automated noteLipocine Inc. filed a Form 8-K on September 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Embrace Change Acquisition Corp. (0001869601) (Filer)
Automated noteEmbrace Change Acquisition Corp filed a Form 8-K indicating it has entered into a material definitive agreement, as disclosed in Item 1.01 of the filing.
- 8-K - WhiteFiber, Inc. (0002042022) (Filer)
Automated noteWhiteFiber, Inc. filed a Form 8-K on September 14, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - ORACLE CORP (0001341439) (Filer)
Automated noteOracle Corp filed a Form 8-K on September 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Artificial Intelligence Technology Solutions Inc. (0001498148) (Filer)
Automated noteArtificial Intelligence Technology Solutions Inc. filed a Form 8-K on September 14, 2026, containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Polaryx Therapeutics, Inc. (0002075320) (Filer)
Automated notePolaryx Therapeutics, Inc. filed a Form 8-K on September 14, 2026 (Accession No. 0001213900-26-099416) reporting Item 5.07, which details the submission of certain matters to a vote of its security holders.
- 8-K/A - BIOLARGO, INC. (0000880242) (Filer)
Automated noteBiolargo, Inc. filed an amended Form 8-K on September 14, 2026, containing a Regulation FD disclosure (Item 7.01) and accompanying financial statements and exhibits (Item 9.01).
- 8-K - abrdn Global Infrastructure Income Fund (0001793855) (Filer)
Automated noteabrdn Global Infrastructure Income Fund filed a Form 8-K on September 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - NorthStrive Acquisition Corp I. (0002133719) (Filer)
Automated noteNorthStrive Acquisition Corp I filed a Form 8-K with the SEC on September 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - BIOVIE INC. (0001580149) (Filer)
Automated noteBiovie Inc. filed a Form 8-K on September 14, 2026, reporting entry into a material definitive agreement and providing its financial statements and related exhibits.
- 8-K - InPoint Commercial Real Estate Income, Inc. (0001690012) (Filer)
Automated noteInPoint Commercial Real Estate Income, Inc. filed a Form 8-K on September 14, 2026, containing a Regulation FD disclosure, other events, and financial statements and exhibits.
- 8-K - Synchrony Financial (0001601712) (Filer)
Automated noteSynchrony Financial filed a Form 8-K on September 14, 2026, containing a Regulation FD disclosure (Item 7.01) and accompanying financial statements and exhibits (Item 9.01).
- 8-K - TransparentBusiness, Inc. (0001740742) (Filer)
Automated noteTransparentBusiness, Inc. filed a Form 8-K on September 14, 2026 reporting departures, elections, appointments, and compensation arrangements for certain officers under Item 5.02.
- 8-K - Fly-E Group, Inc. (0001975940) (Filer)
Automated noteFly-E Group, Inc. filed an 8-K reporting departures, elections or appointments of directors and certain officers, along with related compensatory arrangements, and provided its financial statements and accompanying exhibits.
- 8-K - SharonAI Holdings Inc. (0002068385) (Filer)
Automated noteSharonAI Holdings Inc. filed a Form 8-K reporting entry into a material definitive agreement, the departure and appointment of directors and certain officers with related compensation arrangements, and the inclusion of financial statements and exhibits.
- 8-K - DeFi Development Corp. (0001805526) (Filer)
Automated noteDeFi Development Corp. filed a Form 8-K on September 11, 2026, reporting entry into a material definitive agreement, amendments to its articles of incorporation/bylaws, including a fiscal year change, and accompanying financial statements and exhibits.
- 8-K - T3 Defense Inc. (0001787518) (Filer)
Automated noteT3 Defense Inc. filed a Form 8-K on September 11, 2026, reporting the creation of a direct financial obligation or off-balance-sheet arrangement and including its financial statements and related exhibits.
- 8-K - KULR Technology Group, Inc. (0001662684) (Filer)
Automated noteKULR Technology Group, Inc. filed a Form 8-K reporting the completion of an acquisition or disposition of assets and disclosing departures, elections, appointments, and compensatory arrangements for certain directors and officers.
- 8-K - Volato Group, Inc. (0001853070) (Filer)
Automated noteVolato Group, Inc. filed an 8-K reporting a material definitive agreement, completion of an acquisition, a new financial obligation, unregistered equity sales, modifications to security holder rights, and changes to directors and officers with related compensation arrangements.